TGA-2023-0047-V147

Type II variation for application TGA-2023-0047. Type II variation: Formulation Change for Lecanemabix — critical change

Variation Number
TGA-2023-0047-V147
Type
Type II
Application
TGA-2023-0047
Change
CHG-2022-0147
Status
Pending
Fee
€70,311
Submitted
2023-09-11
Approved
—
Description

Type II variation: Formulation Change for Lecanemabix — critical change